Re:Another drug approved despite review board
by JumpCrisscross on Monday June 24, 2024 @12:22PM
(#40777942)
If we've gotten to Phase III, the risks and side effects are understood as well as they would be for a doctor prescribing off label. While I might not call it arbitrary, I would say it's an unappreciated edge case.
[ Parent
| on HN ]
There are no comments on this comment yet.